Origin of the theory of autoimmunity in COVID-19 and its implications for therapy and treatment.
-
First documentation of the theory of autoimmunity in COVID-19 in April 2020. • 0:27
-
Recent paper highlighting development of ACE2 antibodies after SARS-CoV-2 infection. • 1:45
-
Understanding autoimmunity in COVID-19 can lead to life-saving therapies. • 2:25
-
Steroids are effective in COVID-19 due to autoimmune response principles. • 2:40
-
Autoimmune diseases involve the body attacking normal parts, requiring immune suppression. • 3:20
Origin of Autoimmunity Theory in COVID-19 and its Relation to Antibody Levels
-
Autoimmunity theory in COVID-19 originated from the observation of elevated antibody levels in convalescent and inpatient groups. • 4:00
-
Outpatients without severe symptoms had lower antibody levels compared to convalescent and inpatient groups. • 7:24
-
Research showed that autoantibodies were primarily present in inpatients and convalescent individuals. • 7:47
-
A total of 41 individuals in the inpatient and convalescent groups tested positive for autoantibodies. • 8:01
Origin of the concept of autoimmunity in COVID-19 and its potential impact on pandemic management.
-
Autoimmunity in COVID-19 first discussed over a year ago, leading to collaborations and research breakthroughs. • 8:10
-
Initial skepticism from some experts, but collaborations with researchers like Professor Bruce Uhaul have advanced the concept. • 9:55
-
Autoimmunity in COVID-19 has the potential to change pandemic management strategies. • 10:21
-
Exploration of autoimmunity in COVID-19 symptoms and implications for future research. • 11:00